LGVN Longeveron Inc. Stock Quote

LGVN [NASD]

Index	-	P/E	-	EPS (ttm)	-0.90	Insider Own	20.62%	Shs Outstand	20.03M	Perf Week	19.69%
Market Cap	158.40M	Forward P/E	-	EPS next Y	-0.94	Insider Trans	-0.51%	Shs Float	4.64M	Perf Month	-17.58%
Income	-17.00M	PEG	-	EPS next Q	-0.23	Inst Own	8.60%	Short Float	6.79%	Perf Quarter	17.02%
Sales	1.30M	P/S	121.85	EPS this Y	-353.10%	Inst Trans	-	Short Ratio	0.06	Perf Half Y	168.48%
Book/sh	1.87	P/B	4.49	EPS next Y	-	ROA	-43.40%	Target Price	18.00	Perf Year	36.87%
Cash/sh	1.86	P/C	4.51	EPS next 5Y	-	ROE	-51.70%	52W Range	2.84 - 45.00	Perf YTD	-30.49%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-45.70%	52W High	-81.36%	Beta	-
Dividend %	-	Quick Ratio	13.10	Sales past 5Y	-	Gross Margin	45.20%	52W Low	195.41%	ATR	1.18
Employees	18	Current Ratio	13.10	Sales Q/Q	-83.30%	Oper. Margin	-	RSI (14)	46.53	Volatility	12.30% 13.72%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	-180.20%	Profit Margin	-	Rel Volume	0.05	Prev Close	9.12
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 13 BMO	Payout	-	Avg Volume	5.32M	Price	8.39
Recom	-	SMA20	-11.78%	SMA50	-5.91%	SMA200	2.71%	Volume	246,118	Change	-8.00%

May-13-22 08:00AM	Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results GlobeNewswire +10.80%
07:12AM	LGVN: CEO Leaving but Progress Continues Zacks Small Cap Research
May-09-22 04:15PM	Longeveron Announces CEO Transition GlobeNewswire
08:30AM	Longeveron to Announce First Quarter 2022 Financial Results on May 13, 2022 GlobeNewswire
Apr-28-22 01:53PM	Investors in Longeveron (NASDAQ:LGVN) have made a favorable return of 78% over the past year Simply Wall St. -6.00%
Apr-14-22 08:58AM	Longeveron to Present at Longevity Leaders World Congress; Latinos and Alzheimers Symposium; International Frailty and Sarcopenia Research Conference GlobeNewswire +5.03%
Apr-13-22 08:00AM	Longeveron Enters into Cooperative Research and Development Agreement with the US Department of Veterans Affairs for its Phase 2 Alzheimers Trial GlobeNewswire -6.41%
07:30AM	EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial Benzinga
Apr-08-22 05:02PM	Recession Fears are Creating a Golden Opportunity for Biotech Stocks InvestorPlace -9.21%
Apr-05-22 08:00AM	Longeveron Expands Executive Leadership Team; Appoints K. Chris Min, M.D., Ph.D. as Chief Medical Officer GlobeNewswire -9.73%
Apr-01-22 06:30AM	LGVN: LGVN Publishes Positive Alzheimers Results Zacks Small Cap Research +13.12%
Mar-31-22 08:00AM	Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimers Disease in Alzheimers & Dementia®: The Journal of the Alzheimers Association GlobeNewswire +105.36%
07:48AM	Midday Stock Movers: Longeveron Surges, Dell, UiPath, Expensify Plunge Investing.com
07:30AM	EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal Benzinga
Mar-24-22 08:00AM	Longeveron Presents at Second Euro-Geroscience Conference GlobeNewswire +9.20%
Mar-15-22 04:54PM	My No. 2 Stock Pick For 2022 Rises 100% InvestorPlace
08:00AM	Longeveron to Present at Oppenheimer 32nd Annual Healthcare Conference GlobeNewswire
Mar-11-22 08:00AM	Longeveron Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress GlobeNewswire
06:10AM	LGVN: Longeveron Continues to Make Progress Zacks Small Cap Research
Mar-07-22 08:00AM	Longeveron to Announce Fourth Quarter and Full Year 2021 Financial Results, on March 11, 2022 GlobeNewswire -8.93%
Mar-02-22 08:00AM	Longeveron to Present at Q1 Virtual Investor Summit Conference GlobeNewswire
Feb-17-22 08:00AM	Longeveron Adds Seasoned Biotech Executive Todd Girolamo to Its Board of Directors GlobeNewswire -7.25%
Jan-27-22 05:38PM	TAP Consulting, LLC Buys Vanguard Information Technology ETF, Vanguard Health Care ETF, PayPal ... GuruFocus.com -11.76%
04:49PM	3 Stocks Insiders Are Buying on Market Turbulence InvestorPlace
Jan-26-22 09:10AM	LGVN: Using Cellular Technology to Ease Major Medical Issues Zacks Small Cap Research +13.01%
Jan-25-22 08:00AM	Longeveron to Participate in Phacilitate Advanced Therapies Week GlobeNewswire +5.52%
Jan-17-22 07:32AM	How Much Of Longeveron Inc. (NASDAQ:LGVN) Do Insiders Own? Simply Wall St.
Jan-12-22 08:00AM	Longeveron Announces Publication of Lomecel-B Phase 2b Trial Design in Journal of Frailty and Aging GlobeNewswire -10.16%
Jan-05-22 12:16PM	Here's Why Longeveron Stock Jumped Higher on Wednesday Motley Fool
08:00AM	Longeveron Announces Initiation of Phase 2a Clinical Trial of Lomecel-B for the Treatment of Alzheimers Disease GlobeNewswire
Jan-04-22 08:00AM	Longeveron to Participate in the H.C. Wainwright BioConnect 2022 Virtual Conference GlobeNewswire
Dec-17-21 01:50PM	The 10 Most Shorted Stocks Right Now for Friday, Dec. 17 InvestorPlace +8.89%
Dec-10-21 01:32PM	Why Longeverons Good News Isnt Telling Us the Whole Truth InvestorPlace
Dec-09-21 06:45AM	Is It Too Late to Buy Longeveron Stock? Motley Fool -12.97%
Dec-07-21 01:51PM	7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts InvestorPlace
Dec-06-21 05:00PM	2 Big Stock Bets That Are Insiders Are Buying Now InvestorPlace
08:00AM	Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS) GlobeNewswire
Dec-05-21 02:05PM	Why Longeveron Stock Skyrockted 661.2% in November Motley Fool
05:31AM	Is Longeveron a Good Biotech Stock to Buy? Motley Fool
Dec-03-21 04:30PM	Longeveron Inc. Announces Closing of a $20.5 Million Private Placement GlobeNewswire +11.78%
11:17AM	Here's Why Longeveron Is Surging Today Motley Fool
07:32AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday InvestorPlace
Dec-01-21 03:17AM	Longeveron Inc. Announces Pricing of a $20.5 Million Private Placement GlobeNewswire -22.20%
Nov-30-21 03:20PM	Longeveron Announces Phase 2 Clinical Trial in Japan to Test Safety and Efficacy of Lomecel-B on Aging Frailty Patients GlobeNewswire
12:43PM	Even After a Blistering Rally, Longeveron Is Still Buyable InvestorPlace
Nov-24-21 06:20PM	Longeveron is the short squeeze Reddit Apes can give thanks for this year MarketWatch +145.64%
12:25PM	Why Longeveron Stock Is Skyrocketing Today Motley Fool
Nov-23-21 04:22PM	Retail Traders Jump Back Into Tiny Biotechs Ahead of Holiday Bloomberg -38.94%
Nov-22-21 04:59PM	2 Moonshot Biotechs with 10x Potential InvestorPlace +181.16%
03:42PM	Longeveron stock vaults to another all-time high MarketWatch
Nov-19-21 06:19AM	54 Biggest Movers From Yesterday Benzinga +46.00%
Nov-18-21 02:31PM	Mid-Afternoon Market Update: Dow Falls 75 Points; Dicerna Pharmaceuticals Shares Spike Higher Benzinga +135.27%
12:33PM	Mid-Day Market Update: Macy's Surges After Q3 Results; Amtech Systems Shares Plunge Benzinga
10:57AM	Longeveron stock rockets on very heavy volume after upbeat FDA news MarketWatch
10:37AM	Why Are Longeveron Shares Skyrocketing On Thursday? Benzinga
10:21AM	Mid-Morning Market Update: Markets Down; Kohl's Earnings Top Expectations Benzinga
08:00AM	U.S. Food and Drug Administration Approves Longeverons Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition GlobeNewswire
07:04AM	Longeveron Stock Soars After the FDA Grants Rare Pediatric Disease Designation Investing.com
Nov-14-21 11:55PM	FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Nov-12-21 02:22PM	FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
11:00AM	Last Few Hours to Actively Participate in Longeveron Inc. (LGVN) Class Action - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
10:49AM	LGVN Deadline Alert: Rosen, A Leading Law Firm, Encourages Longeveron Inc. Investors to Secure Counsel Before Important Deadline Today in Securities Class Action - LGVN Newsfile
08:00AM	Longeveron Inc. Provides Corporate Update and Reports Third Quarter 2021 Financial Results GlobeNewswire
07:55AM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Nov-11-21 06:50PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming Deadline LGVN ACCESSWIRE
Nov-10-21 02:54PM	DEADLINE FRIDAY REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
01:15PM	NOVEMBER 12, 2021 LAWSUIT DEADLINE REMINDER FOR LONGEVERON INC. (NASDAQ: LGVN) SHAREHOLDERS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Longeveron Inc. GlobeNewswire
10:45AM	FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Longeveron Inc. Investors with LARGE LOSSES to Secure Counsel Before Important November 12 Deadline in Securities Class Action - LGVN ACCESSWIRE
10:00AM	Last Days to Actively Participate in Longeveron Inc. (LGVN) Class Action - Bronstein, Gewirtz & Grossman, LLC Newsfile
Nov-09-21 03:06PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming Deadline LGVN GlobeNewswire -5.91%
02:48PM	FRIDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
01:55PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:15PM	NOVEMBER 12, 2021 LAWSUIT DEADLINE REMINDER FOR LONGEVERON INC. (NASDAQ: LGVN) SHAREHOLDERS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Longeveron Inc. ACCESSWIRE
09:20AM	Investors with substantial Losses in NASDAQ: LGVN shares should contact the Shareholders Foundation in connection with the Lawsuit against Longeveron Inc. GlobeNewswire
Nov-08-21 01:03PM	FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
12:00PM	SHAREHOLDER ALERT: Robbins LLP Reminds Shareholders of Upcoming Lead Plaintiff Deadline in Class Action Against Longeveron Inc. (LGVN) ACCESSWIRE
11:00AM	LGVN November 12, 2021 Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Longeveron Inc. Investors of Class Action ACCESSWIRE
08:30AM	Longeveron to Release Third Quarter 2021 Financial Results and Hold Conference Call on November 12, 2021 GlobeNewswire
07:40AM	FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Nov-07-21 10:40PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
08:39PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming Deadline - LGVN Newsfile
01:15PM	ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Longeveron Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action LGVN Business Wire
Nov-05-21 06:05PM	7-DAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile -8.45%
03:45PM	IMPORTANT INVESTOR REMINDER - LONGEVERON INC. (NASDAQ: LGVN) LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Longeveron Inc. GlobeNewswire
02:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming Deadline - LGVN ACCESSWIRE
01:42PM	LGVN Deadline Alert: Rosen, A Leading Law Firm, Encourages Longeveron Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action - LGVN Newsfile
12:25PM	7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:00AM	Last Few Days to Actively Participate in Longeveron Inc. (LGVN) Class Action - Bronstein, Gewirtz & Grossman, LLC Business Wire
08:30AM	Longeveron Selects Clinical Research Organization for Phase 2 Alzheimers Disease Trial GlobeNewswire
Nov-04-21 08:15AM	APPROACHING DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE +10.36%
Nov-03-21 10:55PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming Deadline - LGVN PR Newswire
05:15PM	IMPORTANT SHAREHOLDER REMINDER- LONGEVERON INC. (NASDAQ: LGVN) LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Longeveron Inc. ACCESSWIRE
01:34PM	APPROACHING DEADLINE REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Longeveron Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm Newsfile
11:00AM	LGVN Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Longeveron Inc. Investors of Class Action and Lead Plaintiff Deadline: November 12, 2021 ACCESSWIRE
09:58AM	SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Longeveron Inc. (LGVN) Business Wire
07:45AM	APPROACHING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:10AM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Nov-02-21 09:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Longeveron, Boston Beer, Waterdrop, and AppHarvest and Encourages Investors to Contact the Firm GlobeNewswire +8.60%
10:29AM	5 Cheap Stocks Set to Double This Month InvestorPlace
08:00AM	UPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE

Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hare Joshua	Chief Scientific Officer	Apr 19	Sale	10.00	78	780	7,913,263	Apr 20 05:00 PM
Hare Joshua	Chief Scientific Officer	Apr 18	Sale	10.00	19,922	199,290	7,913,341	Apr 20 05:00 PM
Green Geoff	CEO	Oct 13	Buy	3.81	1,000	3,810	139,723	Oct 14 09:00 AM
Soffer Rock	Director	Oct 13	Buy	3.76	12,000	45,120	51,757	Oct 13 06:00 PM
Hare Joshua	Chief Scientific Officer	Oct 12	Buy	3.69	2,500	9,225	7,933,263	Oct 14 09:00 AM
Soffer Rock	Director	Oct 12	Buy	3.57	4,000	14,280	39,757	Oct 13 06:00 PM
Soffer Rock	Director	Oct 11	Buy	3.45	3,900	13,455	35,757	Oct 13 06:00 PM
Hare Joshua	Chief Scientific Officer	Oct 08	Buy	3.39	3,015	10,221	7,930,763	Oct 12 09:30 AM
Hare Joshua	Chief Scientific Officer	Oct 07	Buy	3.38	1,985	6,709	7,927,748	Oct 12 09:30 AM
Lehr Paul T	General Counsel, Secretary	Oct 07	Buy	3.34	1,750	5,845	116,366	Oct 12 09:30 AM
Clavijo James	CFO and Treasurer	Oct 07	Buy	3.34	5,000	16,700	79,598	Oct 12 09:30 AM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience